We are live on ! Find out more
MCM

M28 Capital Management Portfolio holdings

AUM $53.8M
1-Year Est. Return 28.63%
This Fund
S&P 500
This Quarter Est. Return
+59.95%
1 Year Est. Return
+28.63%
3 Year Est. Return
+218.52%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$121M
AUM Growth
+$33.5M
Cap. Flow
+$297K
Cap. Flow %
0.25%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
WVE icon
Wave Life Sciences
WVE
+$1.76M

Top Sells

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$1.43M
2
NEXI
NexImmune, Inc. Common Stock
NEXI
+$28K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
1
Wave Life Sciences
WVE
$1.12B
$37.2M 30.85%
7,373,413
+328,913
+5% +$1.76M
IVVD icon
2
Invivyd
IVVD
$180M
$36.4M 30.19%
9,248,250
– –
RCKT icon
3
Rocket Pharmaceuticals
RCKT
$348M
$15.7M 12.99%
523,280
– –
SLN
4
Silence Therapeutics
SLN
$521M
$6.32M 5.24%
363,800
– –
CRIS icon
5
Curis
CRIS
$9.53M
$5.38M 4.46%
21,098
– –
SWTX
6
DELISTED
SpringWorks Therapeutics
SWTX
$5.21M 4.32%
142,800
-54,900
-28% -$1.43M
BBIO icon
7
BridgeBio Pharma
BBIO
$16.5B
$4.89M 4.05%
121,200
– –
PRQR icon
8
ProQR Therapeutics
PRQR
$243M
$3.78M 3.13%
1,910,600
– –
TGTX icon
9
TG Therapeutics
TGTX
$8.58B
$3.7M 3.06%
216,600
– –
ARWR icon
10
Arrowhead Research
ARWR
$12.1B
$2.06M 1.71%
67,400
– –
NEXI
11
DELISTED
NexImmune, Inc. Common Stock
NEXI
– –
-5,338
Closed -$28K

Similar funds

NCM
Notable Capital Management Menlo Park, California $53.4M AUM 10.98% 1-Year Est. Return
WEO
William E. Oberndorf $53.3M AUM 10.89% 1-Year Est. Return
MML
Mercato Management Legacy Cottonwood Heights, Utah $54.3M AUM
CAM
Copperwood Asset Management Houston, Texas $54.4M AUM
ETCM
Evolutionary Tree Capital Management Alexandria, Virginia $53.2M AUM 13.56% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $54.4M AUM
TP
Toronado Partners San Francisco, California $53M AUM 13.38% 1-Year Est. Return
GMEI
Global Media & Entertainment Investments Nassau, Bahamas $53M AUM 0% 1-Year Est. Return

M28 Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, M28 Capital Management held 11 positions worth $121M, up 38% from $87.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

M28 Capital Management's Q4 2023 filing shows 1 increased, 1 reduced and 1 closed positions. The largest sale was SpringWorks Therapeutics, an estimated $1.43M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • M28 Capital Management added most to Wave Life Sciences in Q4 2023, an estimated $1.76M increase.
  • M28 Capital Management's biggest Q4 2023 reduction was SpringWorks Therapeutics, cutting an estimated $1.43M.
  • M28 Capital Management fully exited NexImmune, Inc. Common Stock in Q4 2023, selling an estimated $28K.
  • M28 Capital Management's ten largest holdings make up 100% of its $121M portfolio in Q4 2023.
  • M28 Capital Management opened 0 new positions and closed 1 in Q4 2023.
  • M28 Capital Management's portfolio value rose 38% quarter-over-quarter to $121M.

Based on M28 Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.